Study to Compare 2 Formulations of LY900014 in Healthy Participants
Status:
Completed
Trial end date:
2018-10-19
Target enrollment:
Participant gender:
Summary
The study involves a comparison of 2 formulations of LY900014, which is a type of fast acting
insulin. Study participants will be administered LY900014 U-100 two times and LY900014 U-200
two times, over 4 study periods, by injection under the skin. Blood samples will be taken to
compare how the body handles the study drugs and how they affect the blood sugar levels. Side
effects and tolerability will be documented. The study will last about 4 weeks, not including
screening and follow up. Screening is required within 28 days prior to the start of the study
and follow up is required at least 2 weeks after the last dose of study drug.